Wells Fargo analyst Mohit Bansal maintained a Buy rating on Neurocrine (NBIX – Research Report) yesterday and set a price target of $180.00.

T cells are white blood cells that are important for adaptive immunity. They have unique cell surface receptors that are generated by randomly assorting genes. These receptors allow T cells to ...

INGREZZA, a selective vesicular monoamine transporter 2 (VMAT2 ... This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

US neuroscience-focused biopharma Neurocrine Biosciences (Nasdaq: NBIX) today presented new data from the long-term, ...

INGREZZA, un inibitore selettivo del trasportatore vescicolare ... Per ulteriori informazioni, consultare i nostri T&C.

INGREZZA, a selective vesicular monoamine transporter ... For more information see our T&C.

"These findings further establish INGREZZA as a highly effective long-term treatment option for individuals living with tardive dyskinesia, regardless of their underlying psychiatric condition ...

SAN DIEGO, March 20, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today presented new data from the long-term, open-label KINECT ® 4 study demonstrating remission of tardive ...